Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111455) titled 'Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy' on Aug. 1.
Study Type: Observational
Primary Sponsor: Zhujiang Hospital
Condition:
Locally Advanced Oral Squamous Cell Carcinoma
Recruitment Status: Recruiting
Date of First Enrollment: July 22, 2025
Target Sample Size: 32
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111455
Published by HT Digital Content Services with permission from Health Daily Digest....